rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Sundeep Agrawal

Director

Company insider

Files Form 4 as: Director, BlossomHill Therapeutics; Director, PAVmed.

In numbers

Trades disclosed
11
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
2
Companies where not an officer
2
First trade
19 Sep 2024
Last trade
10 Aug 2026
Last filed
10 Aug 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
BLSM BlossomHill TherapeuticsDirector · Biotechnology · last 10 Aug 20260 buys · 0 sells
PAVM PAVmedDirector · Medical Devices · last 2 Apr 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
10 Aug 2026filed 10 Aug 2026BLSM BlossomHill TherapeuticsBiotechnologySEC FORM 4 Code C—578,524filing
10 Aug 2026filed 10 Aug 2026BLSM BlossomHill Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code C—578,524filing
10 Aug 2026filed 10 Aug 2026BLSM BlossomHill Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code C—578,524filing
10 Aug 2026filed 10 Aug 2026BLSM BlossomHill TherapeuticsBiotechnologySEC FORM 4 Code C—578,524filing
6 Aug 2026filed 10 Aug 2026BLSM BlossomHill Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—23,904 at $0.00filing
6 Aug 2026filed 10 Aug 2026BLSM BlossomHill Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—23,904 at $0.00filing
2 Apr 2026filed 3 Apr 2026PAVM PAVmedMedical DevicesSEC FORM 4 Code A—13,930 at $0.00filing
2 Apr 2026filed 3 Apr 2026PAVM PAVmedMedical DevicesSEC FORM 4 Code A—13,930 at $0.00filing
30 Sep 2025filed 2 Oct 2025PAVM PAVmedMedical DevicesSEC FORM 4 Code A—150,000 at $0.00filing
21 Oct 2024filed 23 Oct 2024PAVM PAVmedoption or derivative · Medical DevicesSEC FORM 4 Code A—50,000 at $0.00filing
19 Sep 2024filed 20 Sep 2024PAVM PAVmedoption or derivative · Medical DevicesSEC FORM 4 Code A—205,000 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

ORBIMED ADVISORS LLCDirector and 10% owner · Director at BlossomHill Therapeutics, filing Form 4 there in the last year
Carl L. GordonDirector and 10% owner · Director at BlossomHill Therapeutics, filing Form 4 there in the last year
Geoffrey Raymond OxnardChief Medical Officer · Chief Medical Officer at BlossomHill Therapeutics, filing Form 4 there in the last year
John P. SchmidDirector · Director at BlossomHill Therapeutics, filing Form 4 there in the last year
Bihua ChenDirector and 10% owner · Director and 10% owner at BlossomHill Therapeutics, filing Form 4 there in the last year